Evidence map›Paper›PMID 32371566›Full record

ArticleJournal of lipid research2020

Mass spectrometry imaging and LC/MS reveal decreased cerebellar phosphoinositides in Niemann-Pick type C1-null mice.

Koralege C Pathmasiri, Melissa R Pergande, Fernando Tobias, Rima Rebiai, Avia Rosenhouse-Dantsker, Ernesto R Bongarzone, Stephanie M Cologna

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
0.8field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. NPC1-dependent alterations in KNature communications · 2023
    Article
  6. Article
  7. Article
  8. Role of Lysosomal Cholesterol in Regulating PI(4,5)PAdvances in experimental medicine and biology · 2023
    Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Koralege C PathmasiriDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL.
Melissa R PergandeDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL.
Fernando TobiasDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL.
Rima RebiaiLaboratory of Integrated Neuroscience, University of Illinois at Chicago, Chicago, IL; Department of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL.
Avia Rosenhouse-DantskerDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL.
Ernesto R BongarzoneDepartment of Anatomy and Cell Biology, University of Illinois at Chicago, Chicago, IL.
Stephanie M ColognaDepartment of Chemistry, University of Illinois at Chicago, Chicago, IL; Laboratory of Integrated Neuroscience, University of Illinois at Chicago, Chicago, IL. Electronic address: mailto:cologna@uic.edu.
University of Illinois Chicago · US

Funding

Combined Neuroprotection and Metabolic Correction to Treat LeukodystrophiesR01NS065808 · NINDS · UNIVERSITY OF ILLINOIS AT CHICAGO · PI BONGARZONE, ERNESTO ROQUE · 2009 to 2018
$3.0M
NINDS NIH HHS R01 NS065808
6 · The paper itself

Abstract

Niemann-Pick disease type C1 (NPC1) is a lipid storage disorder in which cholesterol and glycosphingolipids accumulate in late endosomal/lysosomal compartments because of mutations in the

Indexed as

Molecular ImagingAnimalsCerebellumChromatography, LiquidMass SpectrometryMiceMice, KnockoutNiemann-Pick Disease, Type CPhosphatidylinositolsPhosphatidylinositolsbisphosphatecholesterolgenetic metabolic disorderlysosomal storage disorderneurodegenerationphosphoinositide signalingphospholipidsignal transduction

Identifiers

PMID32371566
PMCPMC7328050
OpenAlexW3021156425

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.